Health & Traits Publications

Udagawa C, Nakano MH et al.

Pharmacogenomics

Aim: We sought to identify the variants that could predict the risk of nivolumab-induced immune-rela...

Nivolumab-induced immune-related adverse events in cancer

Cavalli M, Eriksson N et al.

Pharmacogenomics

Aim: A follow-up genome-wide association study (GWAS) in an extended cohort of rheumatoid arthritis ...

Alanine aminotransferase level after methotrexate initiation in rheumatoid arthritis

Sundbaum JK, Baecklund E et al.

Pharmacogenomics

Aim: To identify novel genetic variants predisposing to elevation of Alanine aminotransferase (ALT) ...

Alanine aminotransferase level after methotrexate initiation in rheumatoid arthritis

Wolking S, Schulz H et al.

Pharmacogenomics

Aim: Pharmacoresistance is a major burden in epilepsy treatment. We aimed to identify genetic biomar...

Response to antiepileptic drugs in genetic generalized epilepsy

Ala-Mutka EM, Rimpelä JM et al.

Pharmacogenomics

Aim: To recognize genetic associations of hydrochlorothiazide-induced change in serum uric acid (SUA...

Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension

Nishizawa D, Mieda T et al.

Pharmacogenomics

Aim: Opioids are widely used as effective analgesics, but opioid sensitivity is well known to vary w...

Opioid requirements during laparoscopic-assisted colectomy

Liu N, Irvin MR et al.

Pharmacogenomics

Aim: We conducted a genome-wide association study using the Illumina Exome Array to identify coding ...

Warfarin maintenance dose (adjusted for clinical factors)

Koga A, Bani-Fatemi A et al.

Pharmacogenomics

Aims: In the current study, we aimed to compare the prevalence of adverse lifetime events in treatme...

Resistance to antipsychotic treatment in schizophrenia

Hallberg P, Persson M et al.

Pharmacogenomics

Aim: We conducted a genome-wide association study on angiotensin-converting enzyme inhibitor-induced...

Cough in response to angiotensin-converting enzyme inhibitor drugs

Kulkarni D, Song K et al.

Pharmacogenomics

Aim: Pyrexia is a common adverse event (AE) on dabrafenib treatment (monotherapy or combination with...

Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)

Mieda T, Nishizawa D et al.

Pharmacogenomics

Aims: Opioids are widely used as effective analgesics, but opioid sensitivity is well known to vary ...

Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)

Parra EJ, Botton MR et al.

Pharmacogenomics

Aim: Extreme discordant phenotype and genome-wide association (GWA) approaches were combined to expl...

Warfarin maintenance dose